Boothbay Fund Management’s Autolus Therapeutics AUTL Stock Holding History

Bought

Maintained

Sold

Quarter	Market Value	Status	Shares	Change in Stake	Trade Value	Portfolio Weight	Portfolio Position
2024 Q1	–	Sell	-29,822	Closed	-$192K	–	1583
2023 Q4	$192K	Hold	29,822	–	–	﹤0.01%	1341
2023 Q3	$69.5K	Buy	29,822 +2,607	+10%	+$7.43K	﹤0.01%	1602
2023 Q2	$64.8K	Hold	27,215	–	–	﹤0.01%	1661
2023 Q1	$50.1K	Hold	27,215	–	–	﹤0.01%	2021
2022 Q4	$51.7K	Hold	27,215	–	–	﹤0.01%	1872
2022 Q3	$58K	Sell	27,215 -4,963	-15%	-$14.7K	﹤0.01%	2100
2022 Q2	$91K	Sell	32,178 -4,993	-13%	-$15.2K	﹤0.01%	1999
2022 Q1	$155K	Sell	37,171 -19,972	-35%	-$84K	﹤0.01%	1978
2021 Q4	$297K	Sell	57,143 -39,281	-41%	-$236K	0.01%	1262
2021 Q3	$632K	Sell	96,424 -95,396	-50%	-$603K	0.02%	978
2021 Q2	$1.27M	Buy	191,820 +41,908	+28%	+$260K	0.04%	579
2021 Q1	$859K	Buy	+149,912	New	+$1.11M	0.03%	679
2019 Q1	–	Sell	-8,000	Closed	-$263K	–	744
2018 Q4	$263K	Buy	+8,000	New	+$263K	0.04%	419